Having observed that treating PANC1 cells with HMT increased the SAH/SAM ratio (Fig. 1D), we analyzed the localization of MRAS in EGF-stimulated pancreatic cancer cells. This evidence concerns the gene EGF and familial pancreatic carcinoma.